FOXO4-DRI is a research peptide designed to selectively target and clear senescent cells, which accumulate with age and contribute to aging processes.
Disrupts FOXO4-p53 interaction in senescent cells, potentially triggering apoptosis specifically in these aged, dysfunctional cells.
Peptides studied for longevity, cellular senescence, telomere biology, and general anti-aging effects.
This peptide is primarily sold as a research-only compound in lyophilized powder form. It is not approved for human use and is intended for laboratory research purposes only.
Telomerase activation
Exercise mimetic effects
Anti-cancer research
Testosterone support
Browse our verified directory of pharmacies, telehealth providers, and research vendors.
Browse ProvidersThe information provided about FOXO4-DRI is for educational and research purposes only. This content is not intended as medical advice, diagnosis, or treatment recommendation.FOXO4-DRI is a research compound and may not be approved for human use. Always consult with a qualified healthcare provider before considering any peptide therapy. The Peptide List does not sell peptides or provide medical services.
This website is for informational purposes only and does not constitute medical advice. Consult a licensed physician before using any peptides. Provider listings do not constitute endorsements. None of the statements on this site have been evaluated by the FDA.